Article Details
Retrieved on: 2023-09-14 17:39:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sutro is developing mainly antibody-drug conjugates to address solid tumors. Read more about STRO stock here.
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here